AstraZeneca ROA 2006-2018 | AZN

Current and historical return on assets (ROA) values for AstraZeneca (AZN) over the last 10 years.
AstraZeneca Annual ROA - Return on Assets
2017 4.53
2016 5.45
2015 4.71
2014 2.11
2013 4.60
2012 11.71
2011 18.83
2010 14.40
2009 13.74
2008 13.10
2007 12.29
2006 20.26
2005 19.02
AstraZeneca Quarterly ROA - Return on Assets
Q2 2018 0.52
Q1 2018 0.50
Q4 2017 1.99
Q3 2017 1.01
Q2 2017 0.69
Q1 2017 0.84
Q4 2016 2.91
Q3 2016 1.57
Q2 2016 -0.05
Q1 2016 0.97
Q4 2015 1.35
Q3 2015 1.42
Q2 2015 1.26
Q1 2015 1.03
Q4 2014 -0.55
Q3 2014 0.45
Q2 2014 1.36
Q1 2014 0.85
Q4 2013 -0.93
Q3 2013 2.31
Q2 2013 1.54
Q1 2013 1.93
Q4 2012 2.84
Q3 2012 2.90
Q2 2012 3.12
Q1 2012 3.21
Q4 2011 2.83
Q3 2011 6.63
Q2 2011 3.98
Q1 2011 5.35
Q4 2010 2.91
Q3 2010 2.76
Q2 2010 3.87
Q1 2010 5.14
Q4 2009 2.84
Q3 2009 4.08
Q2 2009 3.40
Q1 2009 4.61
Q4 2008 2.67
Q3 2008 3.62
Q2 2008 3.23
Q1 2008 3.11
Q4 2007 2.67
Q3 2007 0.00
Q2 2007 2.94
Q1 2007 5.29
Q4 2006 4.83
Q3 2006 5.66
Q2 2006 5.63
Q1 2006 5.66
Q4 2005 4.94
Q3 2005 5.02
Q2 2005 4.90
Q1 2005 4.20
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $99.745B $22.465B
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $350.789B 16.76
Pfizer (PFE) United States $243.651B 14.26
Novartis AG (NVS) Switzerland $190.263B 16.32
Merck (MRK) United States $178.137B 15.73
AbbVie (ABBV) United States $145.067B 14.17
Novo Nordisk (NVO) Denmark $114.528B 18.31
Eli Lilly (LLY) United States $109.815B 20.33
Sanofi (SNY) France $104.261B 13.20
GlaxoSmithKline (GSK) United Kingdom $99.569B 13.30
Bristol-Myers Squibb (BMY) United States $96.944B 17.55